Athos Bousvaros, MD, MPH
| Department | Gastroenterology |
 |
| Hospital Title | Associate Director, IBD Center | |
| Academic Title | Assistant Professor | |
| Phone | 617-355-2962 | |
| Fax | ||
| Athos Bousvaros | ||
| Location |
300 Longwood Avenue Boston MA 02115 |
Research Overview
Dr. Bousvaros studies the pathogenesis and therapy of inflammatory bowel disease (IBD). Goals of Dr. Bousvaros's research include the identification of microbial pathogens that may trigger exacerbations of Crohn's disease or ulcearative colitis and the evaluation of probiotic therapies in the treatment of IBD.
About Athos Bousvaros
Dr. Bousvaros received an MD from Duke University and an MPH from the Harvard School of Public Health. He completed fellowships at Children's Hospital Boston and Massachusetts General Hospital.
Key Publications
- Bousvaros A, Guandalini S, Baldassano RN, Botelho C, Evans J, Ferry GD, Goldin B, Hartigan L, Kugathasan S, Levy J, Murray KF, Oliva-Hemker M, Rosh JR, Tolia V, Zholudev A, Vanderhoof JA, Hibberd PL. A Randomized, Double-blind Trial of Lactobacillus GG Versus Placebo in Addition to Standard Maintenance Therapy for Children with Crohn's Disease. Inflamm Bowel Dis. 2005;11(9):833-839.
- Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol. 2004;99(11):2235-41.
- Bousvaros A, Kirschner BS, Werlin SL, Parker-Hartigan L, Daum F, Freeman KB, Balint JP, Day AS, Griffiths AM, Zurakowski D, Ferry GD, Leichtner AM. Oral tacrolimus treatment of severe colitis in children. J Pediatr. 2000;137 (6):794-9.
